BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3965102)

  • 1. Microscopic disease at second-look laparotomy in advanced ovarian cancer.
    Copeland LJ; Gershenson DM; Wharton JT; Atkinson EN; Sneige N; Edwards CL; Rutledge FN
    Cancer; 1985 Jan; 55(2):472-8. PubMed ID: 3965102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of second-look laparotomy in the management of patients with ovarian epithelial malignancies.
    Podczaski ES; Stevens CW; Manetta A; Whitney CW; Larson JE; Mortel R
    Gynecol Oncol; 1987 Oct; 28(2):205-14. PubMed ID: 3666578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.
    Rubin SC; Hoskins WJ; Saigo PE; Chapman D; Hakes TB; Markman M; Reichman B; Almadrones L; Lewis JL
    Gynecol Oncol; 1991 Aug; 42(2):137-41. PubMed ID: 1894172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-look laparotomy after chemotherapy in the management of ovarian malignancy.
    Smirz LR; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
    Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):661-8. PubMed ID: 4040706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of müllerian inclusions found at second-look laparotomy in patients with epithelial ovarian neoplasms.
    Copeland LJ; Silva EG; Gershenson DM; Sneige N; Atkinson EN; Wharton JT
    Obstet Gynecol; 1988 May; 71(5):763-70. PubMed ID: 2833713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of second-look laparotomy for ovarian cancer.
    Cain JM; Saigo PE; Pierce VK; Clark DG; Jones WB; Smith DH; Hakes TB; Ochoa M; Lewis JL
    Gynecol Oncol; 1986 Jan; 23(1):14-25. PubMed ID: 3943748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy.
    Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F
    Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings.
    Rubin SC; Randall TC; Armstrong KA; Chi DS; Hoskins WJ
    Obstet Gynecol; 1999 Jan; 93(1):21-4. PubMed ID: 9916949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
    Ngan HY; Wong LC; Ma HK
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration.
    Lippman SM; Alberts DS; Slymen DJ; Weiner S; Aristizabal SA; Luditch A; Davis JR; Surwit EA
    Cancer; 1988 Jun; 61(12):2571-7. PubMed ID: 3365677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.
    Rubin SC; Hoskins WJ; Hakes TB; Markman M; Cain JM; Lewis JL
    Am J Obstet Gynecol; 1988 Nov; 159(5):1094-8. PubMed ID: 3189442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
    Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-look laparotomy in epithelial ovarian cancer.
    Copeland LJ; Vaccarello L; Lewandowski GS
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):155-66. PubMed ID: 8015761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of surgically determined complete responders in advanced ovarian cancer.
    Gershenson DM; Copeland LJ; Wharton JT; Atkinson EN; Sneige N; Edwards CL; Rutledge FN
    Cancer; 1985 Mar; 55(5):1129-35. PubMed ID: 3155643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
    Rubin SC; Jones WB; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
    Obstet Gynecol; 1993 Jul; 82(1):139-42. PubMed ID: 8515914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential.
    Barakat RR; Benjamin I; Lewis JL; Saigo PE; Curtin JP; Hoskins WJ
    Gynecol Oncol; 1995 Dec; 59(3):390-3. PubMed ID: 8522261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.